InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
0.00%
)
US TECH 100
19,318.40
(
0.11%
)
Dow Jones
42,063.36
(
0.00%
)
Brent Oil
73.96
(
0.10%
)
Bitcoin
63,220.52
(
-0.63%
)
Post# of 253177
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

IanFromSI

Send PM Follow Ignore
Followers 10
Posts 702
Boards Moderated 0
Alias Born 03/17/2011

IanFromSI

Re: ilpapa post# 203959

Wednesday, 08/31/2016 10:55:57 PM

Wednesday, August 31, 2016 10:55:57 PM

Post# of 253177
Wouldn't it depend on the MOA for Aducanumab?

e.g. Aduca may attack a root cause (bacterial/fungal/viral/other) that leads to the AB tangles.


Should the slowing of clinical decline be confirmed in ongoing phase 3 clinical trials, it would provide compelling support for the amyloid hypothesis.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up